《现代医学与健康研究》编辑部官网!【中国医师协会系列期刊】
胺碘酮联合缬沙坦治疗高血压 合并阵发性心房颤动的疗效分析
DOI:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R544.1

基金项目:


Efficacy of Amiodarone combined with Valsartan in the treatment of hypertension complicated with paroxysmal atrial fibrillation
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的 探讨胺碘酮联合缬沙坦对高血压合并阵发性心房颤动的疗效及其对患者血压、心功能的影响。方法 以随机数字表法 将重庆市第十三人民医院 2019 年 4 月至 2021 年 2 月收治的 190 例高血压合并阵发性心房颤动患者分为两组,各 95 例。对照组患者接 受胺碘酮联合依那普利治疗,观察组患者接受胺碘酮联合缬沙坦治疗,两组均持续治疗 6 个月。比较两组患者治疗 1、3、6 个月后时的 窦性心律维持率,治疗前后的血压指标、心房颤动发作状况、心功能指标。结果 观察组患者治疗 1、3、6 个月后时窦性心律维持率均 显著高于对照组;与治疗前比,治疗后两组患者收缩压、舒张压均显著降低(均P<0.05),但两组间比较,差异均无统计学意义(均 P>0.05);与治疗前比,治疗后两组患者心室率、心房颤动发作次数均显著减少,且观察组显著少于对照组,心房颤动发作持续时间均 显著缩短,且观察组显著短于对照组;治疗后两组患者左心室射血分数(LVEF)均显著升高,且观察组显著高于对照组;P 波最大时限 (Pmax)、P 波离散度(Pd)均显著降低,且观察组显著低于对照组(均P<0.05)。结论 相较于胺碘酮联合依那普利,胺碘酮联合缬沙 坦治疗高血压合并阵发性心房颤动可在发挥降压效果的同时,更有利于改善患者心功能,抑制心房组织与电重构,维持患者窦性心律。

    Abstract:

    Objective? To investigate the efficacy of Amiodarone combined with Valsartan in the treatment of hypertension complicated with paroxysmal atrial fibrillation, and its effect on blood pressure and cardiac function. Methods 190 patients with hypertension complicated with paroxysmal atrial fibrillation who were treated in The Thirteenth People’s Hospital of Chongqing from April 2019 to February 2021 were divided into two groups by random number table, with 95 cases in each group. Patients in the control group were treated with Amiodarone combined with Enalapril, and patients in the observation group were treated with Amiodarone combined with Valsartan, both groups were treated for 6 months. The maintenance rate of sinus rhythm 1, 3 and 6 months after treatment, blood pressure index, atrial fibrillation attack status, cardiac function index before and after treatment were compared between the two groups. Results The maintenance rate of sinus rhythm in the observation group was significantly higher than that in the control group 1, 3 and 6 months after treatment; compared with before treatment, the systolic and diastolic blood pressure of the two groups decreased significantly after treatment (all P<0.05), but there was no significant difference between the two groups (allP>0.05); compared with before treatment, the ventricular rate and the number of atrial fibrillation attacks in the two groups were significantly less after treatment, and the observation group was significantly less than the control group, the duration of atrial fibrillation attack was significantly shorter, and the observation group was significantly shorter than the control group; after treatment, left ventricular ejection fraction (LVEF) of the two groups were significantly higher, and the observation group was significantly higher than the control group; P wave maximum time limit (Pmax) and P wave dispersion (Pd) in the two groups were significantly lower, and the observation group was significantly lower than those in the control group (allP<0.05). Conclusion? Compared with Amiodarone combined with Enalapril, Amiodarone combined with Valsartan in the treatment of hypertension complicated with paroxysmal atrial fibrillation can not only reduce blood pressure, but also improve patients' cardiac function, inhibit atrial tissue and electrical remodeling, maintain patients' sinus rhythm.

    参考文献
    相似文献
    引证文献
引用本文
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2022-08-24
  • 出版日期:

地址:北京朝阳区北沙滩1号16信箱

邮编:100083

电话:010-64882183 64883630

E-mail:xdyx2020@vip.163.com


温馨提示:建议您使用Chrome80、火狐74+、IE11浏览器 ,当您的浏览器版本过低,可能会影响部分功能正常使用。

现代医学与健康研究 ® 2024 版权所有

技术支持:北京勤云科技发展有限公司